Engineered stone silicosis cases have now reached a jury five times in the United States, and the verdicts get the coverage. The settlements do not, and they are most of the litigation. In the first case to be tried, a Los Angeles County jury returned $52.4 million in August 2024 for a 34-year-old countertop fabricator who had already undergone a double lung transplant — but of the 34 manufacturers he sued, 29 had settled before the trial began and two had won summary judgment, leaving three companies at the table. That ratio, rather than the verdict, is the shape of this litigation: claims resolved one at a time, on confidential terms, by companies that would rather not be on a verdict form.
The first trial, and the arithmetic behind it
On August 7, 2024, a Los Angeles County Superior Court jury awarded $52.4 million to Gustavo Reyes Gonzalez, a 34-year-old countertop fabrication worker who had received a double lung transplant in February 2023. It was the first case of its type to be tried in the United States, and the verdict was returned against three companies — Caesarstone, Cambria and Color Marble (Public Health Watch).
Three is not the number of companies he sued. He sued 34. Twenty-nine settled with him, two obtained summary judgment, and the remaining three went to verdict. The published number is the verdict; the invisible number is the twenty-nine.
The fifth trial, two years later
On August 19, 2026, a jury returned $7.1 million — $2.4 million in economic damages and $4.7 million in non-economic damages — for the family of Gerardo Ramirez-Soriano, an artificial stone countertop fabricator who died at 46. The jury apportioned 2% of fault to two Dal-Tile entities and 1% to Paragon Industries, doing business as Bedrosians Tile & Stone, and 62% to other manufacturers and suppliers. Plaintiffs’ counsel described it as the fifth artificial stone silicosis trial to reach a verdict in the United States and the fourth verdict for a plaintiff (announcement of counsel).
Read the apportionment again. Nearly two-thirds of the fault went to companies that were not in the courtroom when the verdict was read. Some of them had settled. That is not a criticism of the verdict — it is what a verdict form looks like in litigation where most defendants resolve before opening statements.
What “settlement history” means here
There is no federal multidistrict litigation gathering these cases and no court-approved class or aggregate settlement program for them. Each case is filed in state court, worked up on its own record, and settled or tried on its own facts. In California, where most of the filings are, the courts have been asked to coordinate the cases in much the way the state’s asbestos docket is coordinated.
The practical consequences for a worker considering engineered stone silicosis claims are worth stating plainly:
- There is no settlement fund to register with and no published grid of payments. Anyone describing one is describing something else.
- Because resolutions are confidential, the publicly known amounts are verdicts and counsel announcements — a biased sample, weighted toward the cases that went well enough to try.
- Defendants are usually many: the slab manufacturer, distributors, suppliers, and in some filings the makers of respirators and tools. Identifying them is product-identification work, the same kind that asbestos cases run on.
- The deadline is not set by the litigation’s progress. It is set by the statute of limitations in the state where the claim belongs, generally running from diagnosis rather than from the years of dust.
Why the medical record does the deciding
The reason these cases are tried on individual records is that the disease presents so differently. A 2023 case series in JAMA Internal Medicine described 52 California fabrication workers with silicosis: median age 45 at diagnosis, nearly all Latino immigrant men, diagnosis delayed in 58%, advanced scarring already present in 38%, and 19% dead (JAMA Internal Medicine, via PMC).
The verdicts are the visible part. The work is the exposure history, the imaging and the product identification — and that part never makes the news.
For a worker or a family deciding whether to ask, none of the numbers above answer the question. They only explain why the answer has to come from the records rather than from a headline.
This article is general information about how these cases work. It is not legal advice, it does not create an attorney-client relationship, and no two claims are alike. If something here sounds like your situation, the useful next step is a conversation about the facts.
